Micro Cap Growth Fund
Daily price w/o sales charge as of 09/09/2026
$23.59
$0.43
YTD Returns w/o sales charge as of 09/09/2026
21.04%
Overall Morningstar RatingsSmall Growth
as of 08/31/2026
Morningstar rated the Lord Abbett Micro Cap Growth Fund class A share 4, 3 and 5 stars among 521, 499 and 405 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 8/31/2026, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 08/31/2026
- Total Net Assets
- $208.90 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.37%
- Fund Net Expense Ratio
- 1.37%
- Number of Holdings
- 86
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 23.14% | 33.04% | 20.26% | 4.48% | 16.68% | 10.89% |
| Lipper Category Avg. Small-Cap Growth Funds | 14.20% | 18.50% | 13.92% | 2.78% | 10.94% | - |
| Russell Microcap® Growth Index | 13.33% | 23.19% | 21.63% | 2.46% | 9.05% | - |
| w/ sales charge | 16.05% | 25.39% | 17.91% | 3.24% | 15.99% | 10.64% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 35.45% | 57.71% | 22.39% | 5.64% | 18.91% | 11.37% |
| Lipper Category Avg. Small-Cap Growth Funds | 21.87% | 33.76% | 16.35% | 4.55% | 12.40% | - |
| Russell Microcap® Growth Index | 23.50% | 51.30% | 23.15% | 3.30% | 10.79% | - |
| w/ sales charge | 27.66% | 48.65% | 19.99% | 4.40% | 18.21% | 11.12% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
TEN LARGEST HOLDINGS as of 07/31/2026View Portfolio
| Holding | Assets |
|---|---|
| Cogent Biosciences Inc | 2.7% |
| Forte Biosciences Inc | 2.6% |
| Adaptive Biotechnologies Corp | 2.6% |
| Aehr Test Systems | 2.6% |
| Navan Inc | 2.5% |
| Enliven Therapeutics Inc | 2.3% |
| Lindblad Expeditions Holdings Inc | 2.1% |
| CECO Environmental Corp | 2.0% |
| 10X Genomics Inc | 2.0% |
| Pattern Group Inc | 1.9% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 08/31/2026View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 23.14% | 33.04% | 20.26% | 4.48% | 16.68% | 10.89% |
| Lipper Category Avg. Small-Cap Growth Funds | 14.20% | 18.50% | 13.92% | 2.78% | 10.94% | - |
| Russell Microcap® Growth Index | 13.33% | 23.19% | 21.63% | 2.46% | 9.05% | - |
| w/ sales charge | 16.05% | 25.39% | 17.91% | 3.24% | 15.99% | 10.64% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 35.45% | 57.71% | 22.39% | 5.64% | 18.91% | 11.37% |
| Lipper Category Avg. Small-Cap Growth Funds | 21.87% | 33.76% | 16.35% | 4.55% | 12.40% | - |
| Russell Microcap® Growth Index | 23.50% | 51.30% | 23.15% | 3.30% | 10.79% | - |
| w/ sales charge | 27.66% | 48.65% | 19.99% | 4.40% | 18.21% | 11.12% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2025 | 10.74% | 21.84% |
| 2024 | 26.89% | 21.91% |
| 2023 | 5.88% | 9.11% |
| 2022 | -29.27% | -29.76% |
| 2021 | 3.46% | 0.88% |
| 2020 | 79.42% | 40.13% |
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | - |
| 2014 | 10.83% | - |
| 2013 | 78.53% | - |
| 2012 | 2.35% | - |
| 2011 | -5.87% | - |
| 2010 | 33.77% | - |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2026 | 0.21% | 35.18% | - | - |
| 2025 | -17.90% | 15.85% | 13.92% | 2.20% |
| 2024 | 7.64% | 0.07% | 6.89% | 10.21% |
| 2023 | 5.50% | 4.20% | -13.40% | 11.23% |
| 2022 | -17.22% | -22.57% | 8.17% | 2.02% |
| 2021 | 12.29% | -0.15% | -9.42% | 1.87% |
| 2020 | -24.28% | 47.61% | 17.48% | 36.65% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 08/31/2026
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Cogent Biosciences Inc | Health Care | 2.7% |
| Forte Biosciences Inc | Health Care | 2.6% |
| Adaptive Biotechnologies Corp | Health Care | 2.6% |
| Aehr Test Systems | Information Technology | 2.6% |
| Navan Inc | Consumer Discretionary | 2.5% |
| Enliven Therapeutics Inc | Health Care | 2.3% |
| Lindblad Expeditions Holdings Inc | Consumer Discretionary | 2.1% |
| CECO Environmental Corp | Industrials | 2.0% |
| 10X Genomics Inc | Health Care | 2.0% |
| Pattern Group Inc | Consumer Discretionary | 1.9% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Cogent Biosciences Inc | Health Care | 2.7% |
| Forte Biosciences Inc | Health Care | 2.6% |
| Adaptive Biotechnologies Corp | Health Care | 2.6% |
| Aehr Test Systems | Information Technology | 2.6% |
| Navan Inc | Consumer Discretionary | 2.5% |
| Enliven Therapeutics Inc | Health Care | 2.3% |
| Lindblad Expeditions Holdings Inc | Consumer Discretionary | 2.1% |
| CECO Environmental Corp | Industrials | 2.0% |
| 10X Genomics Inc | Health Care | 2.0% |
| Pattern Group Inc | Consumer Discretionary | 1.9% |
| Xometry Inc | Industrials | 1.8% |
| IMAX Corp | Communication Services | 1.8% |
| Hinge Health Inc | Health Care | 1.8% |
| Chefs' Warehouse Inc/The | Consumer Staples | 1.8% |
| Bel Fuse Inc | Information Technology | 1.8% |
| Cardinal Infrastructure Group Inc | Industrials | 1.7% |
| Mama's Creations Inc | Consumer Staples | 1.7% |
| Lincoln Educational Services Corp | Consumer Discretionary | 1.6% |
| Red Violet Inc | Information Technology | 1.6% |
| AAR Corp | Industrials | 1.5% |
| Billiontoone Inc | Health Care | 1.5% |
| Sphere Entertainment Co | Communication Services | 1.4% |
| Neptune Insurance Holdings Inc | Financials | 1.3% |
| Miami International Holdings Inc | Financials | 1.3% |
| Vita Coco Co Inc/The | Consumer Staples | 1.3% |
| Mirum Pharmaceuticals Inc | Health Care | 1.3% |
| Dianthus Therapeutics Inc | Health Care | 1.3% |
| WisdomTree Inc | Financials | 1.3% |
| Transcat Inc | Industrials | 1.3% |
| TAT Technologies Ltd | Industrials | 1.3% |
| Universal Technical Institute Inc | Consumer Discretionary | 1.2% |
| Forum Energy Technologies Inc | Energy | 1.2% |
| Jade Biosciences Inc | Health Care | 1.2% |
| Praxis Precision Medicines Inc | Health Care | 1.2% |
| Marex Group Ltd | Financials | 1.2% |
| Oruka Therapeutics Inc | Health Care | 1.1% |
| Nektar Therapeutics | Health Care | 1.1% |
| Celcuity Inc | Health Care | 1.1% |
| PTC Therapeutics Inc | Health Care | 1.1% |
| Navitas Semiconductor Corp | Information Technology | 1.1% |
| Legence Corp | Industrials | 1.1% |
| Fastly Inc | Information Technology | 1.1% |
| uniQure NV | Health Care | 1.0% |
| Mercury Systems Inc | Industrials | 1.0% |
| VSE Corp | Industrials | 1.0% |
| Ouster Inc | Information Technology | 1.0% |
| Agilysys Inc | Information Technology | 1.0% |
| MYR Group Inc | Industrials | 1.0% |
| Ambiq Micro Inc | Information Technology | 1.0% |
| Relay Therapeutics Inc | Health Care | 1.0% |
| Twist Bioscience Corp | Health Care | 1.0% |
| Citi Trends Inc | Consumer Discretionary | 0.9% |
| Willdan Group Inc | Industrials | 0.9% |
| Dave Inc | Financials | 0.9% |
| Penguin Solutions Inc | Information Technology | 0.9% |
| Newamsterdam Pharma Co NV | Health Care | 0.9% |
| Alamar Biosciences Inc | Health Care | 0.8% |
| Ooma Inc | Information Technology | 0.8% |
| BlackSky Technology Inc | Industrials | 0.8% |
| Rapport Therapeutics Inc | Health Care | 0.8% |
| Standex International Corp | Industrials | 0.8% |
| Tyra Biosciences Inc | Health Care | 0.8% |
| American Public Education Inc | Consumer Discretionary | 0.8% |
| StoneX Group Inc | Financials | 0.7% |
| Helios Technologies Inc | Industrials | 0.7% |
| Terawulf Inc | Information Technology | 0.7% |
| Unusual Machines Inc /US | Information Technology | 0.7% |
| CG oncology Inc | Health Care | 0.7% |
| Applied Digital Corp | Information Technology | 0.7% |
| Argan Inc | Industrials | 0.7% |
| Warby Parker Inc | Consumer Discretionary | 0.7% |
| Sezzle Inc | Financials | 0.7% |
| Innodata Inc | Industrials | 0.6% |
| Extreme Networks Inc | Information Technology | 0.6% |
| Gilat Satellite Networks Ltd | Information Technology | 0.6% |
| Cleanspark Inc | Information Technology | 0.5% |
| Applied Optoelectronics Inc | Information Technology | 0.5% |
| Mayville Engineering Co Inc | Industrials | 0.5% |
| SharonAI Holdings Inc | Information Technology | 0.5% |
| Applied Aerospace & Defense Inc | Industrials | 0.5% |
| HeartFlow Inc | Health Care | 0.4% |
| Vishay Precision Group Inc | Information Technology | 0.4% |
| Liftoff Mobile Inc | Communication Services | 0.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 08/31/2026
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
0.20%
|
|
| Real Estate | 0.00% | |
| Utilities | 0.00% | |
| Consumer Discretionary |
 1.10%
|
|
| Consumer Staples |
0.90%
|
|
| Energy |
1.50%
|
|
| Financials |
0.20%
|
|
| Health Care |
0.40%
|
|
| Industrials |
7.40%
|
|
| Information Technology |
4.60%
|
|
| Materials | 0.00% |
Portfolio Details as of 08/31/2026
- Total Net Assets
- $208.90 M
- Number of Holdings
- 86
- Weighted Average Market Cap.
- 2.7 B
- P/B Ratio
- 5.0x
- P/E Ratio
- 43.8x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 09/09/2026
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2026 | 11/24/2026 | 11/24/2026 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 09/09/2026
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $25.03 |
| $50,000 to $99,999 | 4.75% | 4.00% | $24.77 |
| $100,000 to $249,999 | 3.95% | 3.25% | $24.56 |
| $250,000 to $499,999 | 2.75% | 2.25% | $24.26 |
| $500,000 to $999,999 | 1.95% | 1.75% | $24.06 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $23.59 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 08/31/2026
| Fund Gross Expense Ratio | 1.37% |
| Fund Net Expense Ratio | 1.37% |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
2025 Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
2026 Semi-Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|